Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

Completed · Phase 3

Conditions studied: HIV Infections, Streptococcus Pneumoniae

In brief

Purpose: To study the immune response of the newly licensed pneumococcal conjugate vaccine (PCV) in comparison to the pneumococcal polysaccharide vaccine (PPV) to determine if a significantly better immunologic response to boosting can be elicited in patients previously vaccinated with PPV.

Key facts

Study ID

NCT00622843

Run by

Henry M. Jackson Foundation for the Advancement of Military Medicine

People needed

275

Starts

2002-12-01

Expected to finish

2013-07-01

Last updated by the study team

2025-06-08

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

Where it is running

• Naval Medical Center San Diego — San Diego, California, United States
• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
• Tripler Army Medical Center — Tripler AMC, Hawaii, United States
• National Naval Medical Center — Bethesda, Maryland, United States
• San Antonio Military Medical Center — Lackland Air Force Base, Texas, United States
• Naval Medical Center Portsmouth — Portsmouth, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.